200 related articles for article (PubMed ID: 19378887)
1. Carvedilol therapy in pediatric patients with dilated cardiomyopathy.
Askari H; Semizel E; Bostan OM; Cil E
Turk J Pediatr; 2009; 51(1):22-7. PubMed ID: 19378887
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
Rusconi P; Gómez-Marín O; Rossique-González M; Redha E; Marín JR; Lon-Young M; Wolff GS
J Heart Lung Transplant; 2004 Jul; 23(7):832-8. PubMed ID: 15261177
[TBL] [Abstract][Full Text] [Related]
3. Treatment of dilated cardiomyopathy with carvedilol in children.
Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
[TBL] [Abstract][Full Text] [Related]
4. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R
Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience.
Bruns LA; Chrisant MK; Lamour JM; Shaddy RE; Pahl E; Blume ED; Hallowell S; Addonizio LJ; Canter CE
J Pediatr; 2001 Apr; 138(4):505-11. PubMed ID: 11295713
[TBL] [Abstract][Full Text] [Related]
6. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
Tatli E; Kurum T
Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
[TBL] [Abstract][Full Text] [Related]
7. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
Metra M; Nodari S; Garbellini M; Boldi E; Rosselli F; Milan E; Giubbini R; Dei Cas L
Cardiologia; 1997 May; 42(5):503-12. PubMed ID: 9289367
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of carvedilol in infants with dilated cardiomyopathy: a preliminary report.
Gachara N; Prabhakaran S; Srinivas S; Farzana F; Krishnan U; Shah MJ
Indian Heart J; 2001; 53(1):74-8. PubMed ID: 11456146
[TBL] [Abstract][Full Text] [Related]
9. Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol.
Giardini A; Formigari R; Bronzetti G; Prandstraller D; Donti A; Bonvicini M; Picchio FM
Cardiol Young; 2003 Aug; 13(4):333-6. PubMed ID: 14694952
[TBL] [Abstract][Full Text] [Related]
10. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
Metra M; Nardi M; Giubbini R; Dei Cas L
J Am Coll Cardiol; 1994 Dec; 24(7):1678-87. PubMed ID: 7963115
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy.
Horenstein MS; Ross RD; Singh TP; Epstein ML
Pediatr Cardiol; 2002; 23(1):100-2. PubMed ID: 11922497
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
Rhodes J; Margossian R; Darras BT; Colan SD; Jenkins KJ; Geva T; Powell AJ
Pediatr Cardiol; 2008 Mar; 29(2):343-51. PubMed ID: 17885779
[TBL] [Abstract][Full Text] [Related]
13. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
Huang M; Zhang X; Chen S; Sun Y; Xiao Y; Sun J; Huang M; Chen S; Liu F
Pediatr Cardiol; 2013 Mar; 34(3):680-5. PubMed ID: 23108482
[TBL] [Abstract][Full Text] [Related]
14. Clinical and echocardiographic outcome in patients receiving carvedilol for treatment of dilated cardiomyopathy.
Saxena A; Anil OM; Juneja R
Indian J Pediatr; 2013 Jul; 80(7):549-54. PubMed ID: 23412984
[TBL] [Abstract][Full Text] [Related]
15. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
16. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
17. [Prospective evaluation of effect of carvedilol therapy on heart rate variability in patients with dilated cardiomyopathy].
Hoffmann J; Grimm W; Menz V; Hufnagel G; Maisch B
Z Kardiol; 1999 Sep; 88(9):653-60. PubMed ID: 10525927
[TBL] [Abstract][Full Text] [Related]
18. [Is myocardial impairment in idiopathic dilated hypertrophic cardiomyopathy reversible by carvedilol?: a case report].
Ochiai N; Furukawa K; Ebizawa T; Yagi T; Akashi K; Nakamura T; Azuma A; Sugihara H
J Cardiol; 2000 Sep; 36(3):183-9. PubMed ID: 11022654
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-induced cardiomyopathy treated with carvedilol.
Fazio S; Palmieri EA; Ferravante B; Bonè F; Biondi B; Saccà L
Clin Cardiol; 1998 Oct; 21(10):777-9. PubMed ID: 9789703
[TBL] [Abstract][Full Text] [Related]
20. Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
Maunoury C; Acar P; Sidi D
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1651-6. PubMed ID: 14504829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
